Merck Sharp & Dohme
Executive Director, Outcomes Research, Hematology and Prostate Cancer
Merck Sharp & Dohme, Rahway, New Jersey, us, 07065
Job Description
This position resides within our company's Value and Implementation (V&I), Oncology Outcomes Research organization, which is responsible for real-world evidence generation and outcomes research to enable sustained patient access to our company’s innovations and improve patient health outcomes. Under the guidance of a senior leader, the Executive Director will be responsible for developing a value and implementation plan for the company's Hematology and Prostate malignancy portfolio in close partnership with global and scientific affairs (GMSA) and other cross-functional teams. Specifically, the executive director will lead a team of outcomes research professionals to develop value evidence strategies and generate real world and economic evidence for the company's Hematology and Prostate Cancer portfolio to meet the value evidence needs of clinicians, payers, policymakers, HTA/reimbursement agencies, and health systems globally. The ability to successfully participate in and lead cross functional teams is a critical part of this role.
The Executive Director has scientific and budgetary oversight for all outcomes research activities conducted by the team. These include prospective and retrospective observational studies to characterize disease burden and epidemiology, treatment patterns, healthcare resource utilization and costs, physician and patient satisfaction surveys, clinical and patient reported outcomes assessments, systematic reviews and meta-analyses, and economic modelling. Key responsibilities also include overseeing the development of American Managed Care Pharmacy (AMCP) dossiers for US payers, and Global Value Dossiers for use by local subsidiaries in their HTA submissions.
The Executive Director is expected to contribute to product development and marketing strategies throughout the lifecycle to ensure that product value is defined and developed to achieve optimal market/patient access and reimbursement. The incumbent is expected to work cross-functionally with clinical development, medical affairs, biostatistics, market access, commercial and country affiliates and may have direct interactions with health technology assessment (HTA) agencies, reimbursement decision makers, care pathways or other decision making and policy setting groups.
Primary Responsibilities:
Lead, inspire, manage, and provide strategic direction to a team of outcomes research professionals.
Lead value evidence and outcomes research strategy development for all therapies in Hematology and Prostate Cancer area through a cross-functional value and implementation (V&I) team.
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing and promotion of our Company's products.
Develop a strong matrix relationship with clinical development, BARDS (Biostatistics and Research Decision Sciences), medical affairs, market access, commercial and key markets to ensure that clinical, commercial and access strategies fully reflect payer/HTA requirements.
Represent the perspectives and experiences of their team to shape the strategy and function of the outcomes research organization within the company through involvement in the extended leadership team and leading strategic initiatives.
Develop effective partnerships with internal stakeholders and external thought leaders in real world evidence, health economics, health care policy, and HTA to maintain our understanding of the external environment, inform our value evidence strategies and shape the environment for innovative applications of HEOR.
Maintain awareness of new scientific and methodological developments within therapeutic area and encourage appropriate application of new methods to outcomes research studies.
Accountable for innovative and effective dissemination of value evidence deliverables through presentations at scientific congresses, publications in peer reviewed journals, press releases, promotional materials and social media.
Qualifications
Doctoral degree (PhD, DrPH, ScD) in relevant discipline (health services research, outcomes research, epidemiology, public health, health economics, pharmacoeconomics, pharmacy administration).
Experience10+ years post degree with pharmaceutical industry experience (experience in oncology preferred).
US and Puerto Rico Residents Only:
Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here if you need an accommodation during the application or hiring process.
We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics.
U.S. Hybrid Work Model
Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, Monday - Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence.
Expected US salary range:
$243,500.00 - $383,300.00
Available benefits include bonus eligibility, long term incentive if applicable, health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and sick days.
Search Firm Representatives Please Read CarefullyMerck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities.
Employee Status:
Regular
Job Posting End Date:
11/7/2024
A job posting is effective until 11:59:59PM on the day
BEFORE
the listed job posting end date. Please ensure you apply to a job posting no later than the day
BEFORE
the job posting end date.
Requisition ID:
R318872
#J-18808-Ljbffr
This position resides within our company's Value and Implementation (V&I), Oncology Outcomes Research organization, which is responsible for real-world evidence generation and outcomes research to enable sustained patient access to our company’s innovations and improve patient health outcomes. Under the guidance of a senior leader, the Executive Director will be responsible for developing a value and implementation plan for the company's Hematology and Prostate malignancy portfolio in close partnership with global and scientific affairs (GMSA) and other cross-functional teams. Specifically, the executive director will lead a team of outcomes research professionals to develop value evidence strategies and generate real world and economic evidence for the company's Hematology and Prostate Cancer portfolio to meet the value evidence needs of clinicians, payers, policymakers, HTA/reimbursement agencies, and health systems globally. The ability to successfully participate in and lead cross functional teams is a critical part of this role.
The Executive Director has scientific and budgetary oversight for all outcomes research activities conducted by the team. These include prospective and retrospective observational studies to characterize disease burden and epidemiology, treatment patterns, healthcare resource utilization and costs, physician and patient satisfaction surveys, clinical and patient reported outcomes assessments, systematic reviews and meta-analyses, and economic modelling. Key responsibilities also include overseeing the development of American Managed Care Pharmacy (AMCP) dossiers for US payers, and Global Value Dossiers for use by local subsidiaries in their HTA submissions.
The Executive Director is expected to contribute to product development and marketing strategies throughout the lifecycle to ensure that product value is defined and developed to achieve optimal market/patient access and reimbursement. The incumbent is expected to work cross-functionally with clinical development, medical affairs, biostatistics, market access, commercial and country affiliates and may have direct interactions with health technology assessment (HTA) agencies, reimbursement decision makers, care pathways or other decision making and policy setting groups.
Primary Responsibilities:
Lead, inspire, manage, and provide strategic direction to a team of outcomes research professionals.
Lead value evidence and outcomes research strategy development for all therapies in Hematology and Prostate Cancer area through a cross-functional value and implementation (V&I) team.
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing and promotion of our Company's products.
Develop a strong matrix relationship with clinical development, BARDS (Biostatistics and Research Decision Sciences), medical affairs, market access, commercial and key markets to ensure that clinical, commercial and access strategies fully reflect payer/HTA requirements.
Represent the perspectives and experiences of their team to shape the strategy and function of the outcomes research organization within the company through involvement in the extended leadership team and leading strategic initiatives.
Develop effective partnerships with internal stakeholders and external thought leaders in real world evidence, health economics, health care policy, and HTA to maintain our understanding of the external environment, inform our value evidence strategies and shape the environment for innovative applications of HEOR.
Maintain awareness of new scientific and methodological developments within therapeutic area and encourage appropriate application of new methods to outcomes research studies.
Accountable for innovative and effective dissemination of value evidence deliverables through presentations at scientific congresses, publications in peer reviewed journals, press releases, promotional materials and social media.
Qualifications
Doctoral degree (PhD, DrPH, ScD) in relevant discipline (health services research, outcomes research, epidemiology, public health, health economics, pharmacoeconomics, pharmacy administration).
Experience10+ years post degree with pharmaceutical industry experience (experience in oncology preferred).
US and Puerto Rico Residents Only:
Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here if you need an accommodation during the application or hiring process.
We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics.
U.S. Hybrid Work Model
Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, Monday - Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence.
Expected US salary range:
$243,500.00 - $383,300.00
Available benefits include bonus eligibility, long term incentive if applicable, health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and sick days.
Search Firm Representatives Please Read CarefullyMerck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities.
Employee Status:
Regular
Job Posting End Date:
11/7/2024
A job posting is effective until 11:59:59PM on the day
BEFORE
the listed job posting end date. Please ensure you apply to a job posting no later than the day
BEFORE
the job posting end date.
Requisition ID:
R318872
#J-18808-Ljbffr